Related references
Note: Only part of the references are listed.Inhibition of Neuronal Voltage-Gated Sodium Channels by Brilliant Blue G
Sooyeon Jo et al.
MOLECULAR PHARMACOLOGY (2011)
P2X7 receptor-deficient mice are susceptible to bone cancer pain
Rikke Rie Hansen et al.
PAIN (2011)
Central sensitization: Implications for the diagnosis and treatment of pain
Clifford J. Woolf
PAIN (2011)
Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Synthesis and in vivo evaluation of 3-substituted gababutins
David C. Blakemore et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist
Christine E. Brotherton-Pleiss et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonist
Xiangyang Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist
Joel R. Gever et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
P2X purinergic receptor ligands: recently patented compounds
Hendra Gunosewoyo et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Emerging structures and ligands for P2X3 and P2X4 receptors—towards novel treatments of neuropathic pain
Christa E. Müller
Purinergic Signalling (2010)
The neural-glial purinergic receptor ensemble in chronic pain states
Michael F. Jarvis
TRENDS IN NEUROSCIENCES (2010)
The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1αβ knockout mice
Prisca Honore et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression
John R. Cashman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X3/P2X2/3 antagonist for the treatment of pain
Alam Jahangir et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X3/P2X2/3 antagonist for the treatment of pain
David S. Carter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Using the Golden Triangle to optimize clearance and oral absorption
Ted W. Johnson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors
Diana L. Donnelly-Roberts et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Cellular and Molecular Mechanisms of Pain
Allan I. Basbaum et al.
CELL (2009)
Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds
Jens-Uwe Peters et al.
CHEMMEDCHEM (2009)
Structure-Brain Exposure Relationships in Rat and Human Using a Novel Data Set of Unbound Drug Concentrations in Brain Interstitial and Cerebrospinal Fluids
Markus Friden et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Antagonists of the P2X7 Receptor. From Lead Identification to Drug Development
Simon D. Guile et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Morphine Enhances Microglial Migration through Modulation of P2X4 Receptor Signaling
Ryan J. Horvath et al.
JOURNAL OF NEUROSCIENCE (2009)
P2X4-Receptor-Mediated Synthesis and Release of Brain-Derived Neurotrophic Factor in Microglia Is Dependent on Calcium and p38-Mitogen-Activated Protein Kinase Activation
Tuan Trang et al.
JOURNAL OF NEUROSCIENCE (2009)
Crystal structure of the ATP-gated P2X4 ion channel in the closed state
Toshimitsu Kawate et al.
NATURE (2009)
ATP-gated P2X cation-channels
Michael F. Jarvis et al.
NEUROPHARMACOLOGY (2009)
The P2X7 receptor-pannexin connection to dye uptake and IL-1β release
Pablo Pelegrin et al.
PURINERGIC SIGNALLING (2009)
Reconstruction of the P2X2 Receptor Reveals a Vase-Shaped Structure with Lateral Tunnels above the Membrane
Kazuhiro Mio et al.
STRUCTURE (2009)
Physiochemical drug properties associated with in vivo toxicological outcomes
Jason D. Hughes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Blood-brain barrier permeability considerations for CNS-targeted compound library design
Stephen A. Hitchcock
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
The P2X7 receptor as a therapeutic target
Romeo Romagnoli et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Fibronectin/integrin system is involved in P2X4 receptor upregulation in the spinal cord and neuropathic pain after nerve injury
Makoto Tsuda et al.
GLIA (2008)
Phosphoinositides Regulate P2X4 ATP-Gated Channels through Direct Interactions
Louis-Philippe Bernier et al.
JOURNAL OF NEUROSCIENCE (2008)
Up-Regulation of P2X4 Receptors in Spinal Microglia after Peripheral Nerve Injury Mediates BDNF Release and Neuropathic Pain
Lauriane Ulmann et al.
JOURNAL OF NEUROSCIENCE (2008)
Characterization of N-(Adamantan-1-ylmethyl)-5-[(3R-aminopyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 Antagonist in Animal Models of Pain and Inflammation
Daniel C. Broom et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1β, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice
Cataldo Martucci et al.
PAIN (2008)
Painful purinergic receptors
Diana Donnelly-Roberts et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury
Makoto Tsuda et al.
GLIA (2008)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Modification of neuropathic pain sensation through microglial ATP receptors
Kazuhide Inoue et al.
PURINERGIC SIGNALLING (2007)
Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPS-induced activation
Ramin Raouf et al.
NEUROPHARMACOLOGY (2007)
From tyrosine to glycine:: Synthesis and biological activity of potent antagonists of the purinergic P2X7 receptor
Romeo Romagnoli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states
D. L. Donnelly-Roberts et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Intrathecal administration of atp produces long-lasting allodynia in rats: Differential mechanisms in the phase of the induction and maintenance
T. Nakagawa et al.
NEUROSCIENCE (2007)
P2x7-related modulation of pathological nociception in rats
S. McGaraughty et al.
NEUROSCIENCE (2007)
Physiology and pathophysiology of purinergic neurotransmission
Geoffrey Burnstock
PHYSIOLOGICAL REVIEWS (2007)
Timeline - Ideas about pain, a historical view
Edward R. Perl
NATURE REVIEWS NEUROSCIENCE (2007)
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino)methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat
Prisca Honore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
P2X receptors as cell-surface ATP sensors in health and disease
Baljit S. Khakh et al.
NATURE (2006)
P2X receptor ligands and pain
Char-Chang Shieh et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2006)
Pharmacology of P2X channels
Joel R. Gever et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2006)
Global mapping of pharmacological space
Gaia V. Paolini et al.
NATURE BIOTECHNOLOGY (2006)
Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists
Derek W. Nelson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The P2X7 receptor:: A key player in IL-1 processing and release
Davide Ferrari et al.
JOURNAL OF IMMUNOLOGY (2006)
Interleukin-1αβ gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain
P Honore et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
The function of microglia through purinergic receptors: Neuropathic pain and cytokine release
K Inoue
PHARMACOLOGY & THERAPEUTICS (2006)
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
JAM Coull et al.
NATURE (2005)
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
IP Chessell et al.
PAIN (2005)
Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms
RD Beigi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain
JAM Coull et al.
NATURE (2003)
Impairment of interleukin-1 (IL-1) signaling reduces basal pain sensitivity in mice: genetic, pharmacological and developmental aspects
G Wolf et al.
PAIN (2003)
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain
MF Jarvis
EXPERT OPINION ON THERAPEUTIC TARGETS (2003)
A comparison of physiochemical property profiles of development and marketed oral drugs
MC Wenlock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Effects of A-317491, a novel and selective P2X(3)/P2X(2/3) receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration
S McGaraughty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
A-317491, a novel potent and selective nonnucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat
MF Jarvis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Purine and pyrimidine (P2) receptors as drug targets
KA Jacobson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response
JM Labasi et al.
JOURNAL OF IMMUNOLOGY (2002)
Rapid secretion of interleukin-1β by microvesicle shedding
A MacKenzie et al.
IMMUNITY (2001)
Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue
MF Jarvis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Regular articles -: Human μ-opioid receptor overexpressed in Sf9 insect cells functionally coupled to endogenous Gi/o proteins
Q Wei et al.
CELL RESEARCH (2000)
ATP in human skin elicits a dose-related pain response which is potentiated under conditions of hyperalgesia
SG Hamilton et al.
BRAIN (2000)
Share Paper
